Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Fluidigm BioMark System Sales Surpass The Century Mark

fluidigmpr27-image.jpgFluidigm Corporation has announced that sales of its flagship BioMark™ System for Genetic Analysis have now surpassed 100 cumulative units in the field. The BioMark system, based on proprietary microfluidic chips called integrated fluidic circuits (IFCs), provides high throughput real-time qPCR enabling researchers to streamline their experimental workflow, increase throughput and lower costs.

In addition to real-time qPCR, the BioMark system also offers digital PCR, gene expression and genotyping capabilities for researchers. The versatility, throughput and ease-of-use of the system, combined with the IFC technology, enable leading research labs across the United States, Europe, Japan and Asia to perform leading-edge research on cancer, stem cells, non-invasive prenatal diagnostics, as well as fishery management of wild salmon and much more.

"This is Fluidigm's first system to ship more than 100 units and I'm extremely proud of the accomplishment. Achieving this shipment milestone indicates that we are making a contribution to life science research and to applied markets already, yet we've only just begun," said Gajus Worthington, president and chief executive officer of Fluidigm.

Fluidigm's BioMark system was introduced in November 2006.

Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturising and integrating liquid handling components on a single microfluidic device (IFC). Fluidigm's systems, consisting of instrumentation, software and single-use chips, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.

For more information, please visit www.fluidigm.com

Fluidigm, the Fluidigm logo, Topaz, BioMark, Dynamic Array, Digital Array, Access Array and NanoFlex are trademarks or registered trademarks of Fluidigm Corporation. All other trademarks are the property of their respective owners.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events